| Sanofi-Aventis (Suisse) SA - Lantus, solution injectable en cartouche |
| 55346 | | 01 | | Lantus | | solution injectable en cartouche | | A10AE04 | | Insulin glargin | | 16.05.2002 | | |
|
| Composition |
| insulinum glarginum 3.6378 mg corresp. insulinum glarginum 100 U., zinci chloridum, glycerolum (85 per centum), acidum hydrochloridum concentratum, natrii hydroxidum 0.1 mg, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml. |
| Packungsbestandteile |
| solution injectable en cartouche | | | | | | | | Principe actif | Concentr. |
|---|
| Insuline Glargine | 3.6378 mg/ml correspond Insuline Glargine 100 U/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Insuline Glargine | 100 U |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Hydrochloridum Concentratum | | | Glycerol | | | Metacresol | | | Sodium Hydroxide | 0.1 mg/ml | | Zinci Chlorure | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 5 x 3 ml | 47.94 | 68.35 | B | LS | Non |
|
